66 results
Page 3 of 4
8-K
EX-99.1
9k7 chjs0u9fbbzkm4
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am
8-K
EX-99.1
nbhuar9j7t9c62596
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
424B5
m61gvixfl1gk qx96
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
sp43srd0q4
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
p5296
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
6or274b 430un6i
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
udb 5dv8a8acl3bb4v4
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
1e5 vynvkrk
15 Jun 20
Regulation FD Disclosure
7:21am
424B5
tm1xeayu91an0sjgb
12 May 20
Prospectus supplement for primary offering
5:02pm
424B5
j6adlt
11 May 20
Prospectus supplement for primary offering
4:12pm